A primary safety study of the offspring from the unplanned pregnancy during maternal exposure of novel coronavirus pneumonia (COVID-19) vaccines

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100048512

Enrollment

Unknown

Registered

2021-07-09

Start date

2021-01-01

Completion date

Unknown

Last updated

2022-03-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pregnancy

Interventions

None listed

Eligibility

Sex/Gender

Female

Age

18 Years to 45 Years

Inclusion criteria

Inclusion criteria: 1. Pregnant women who accidentally expose to COVID-19 vaccines (include in exposing to COVID-19 vaccines alone and exposing to other medicine together); 2. Pregnant women who volunteered to participate in this study with informed consent.

Exclusion criteria

Exclusion criteria: 1. Pregnant women who can't provide accurate information of exposure time; 2. Pregnant women with mental illness or physical disability who can't participate in this study.

Design outcomes

Primary

Measure	Time frame
congenital defect;spontaneous abortion;induced abortion;adverse events of fetus;premature labour;adverse events of neonatus;birth weight;Apgar scores;	—

Secondary

Measure	Time frame
adverse events of children;	—

Countries

China

Contacts

Public ContactZheng Caihong

Women's Hospital, School of Medicine Zhejiang University

chzheng@zju.edu.cn+86 0571-89991730

Outcome results